West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2026 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2026 Earnings Call Transcript April 23, 2026West Pharmaceutical Services, Inc. beats earnings expectations.
West Pharmaceutical Services Inc (WST)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bayforest Capital Theodoros Tsagaris | 177 | $44,363 | -41% | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $105.14 | 54 | $5,677.40 | 66,251 | 2019-02-28 | Filing | |
| $110.55 | 57 | $6,301.52 | 66,197 | 2018-07-31 | Filing | |
| $93.94 | 335 | $31,468.79 | 66,475 | 2017-10-17 | Filing | |
| $88.89 | 275 | $24,444.31 | 56,540 | 2018-05-15 | Filing | |
| $84.53 | 332 | $28,063.30 | 51,831 | 2016-12-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $305.20 | 2,817 | $859,753.47 | 16,828 | 2026-04-27 | Filing | |
| $300.67 | 896 | $269,399.24 | 1,523 | 2026-04-27 | Filing | |
| $310.40 | 225 | $69,840.00 | 1,253 | 2024-10-29 | Filing | |
| $310.40 | 478 | $148,371.20 | 1,478 | 2024-10-29 | Filing | |
| $300.00 | 500 | $150,000.00 | 1,478 | 2024-08-19 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 660,084 | $165,443,452 | 0.24% | |
| 2. | 408,990 | $102,509,253 | 0.03% | |
| 3. | 261,442 | $65,527,942 | 1.6% | |
| 4. | 226,021 | $56,649,903 | 6.76% | |
| 5. | 203,556 | $51,019,276 | 0.62% |
News See All
Is West Pharmaceutical Services, Inc. (WST) A Good Stock To Buy Now?
Is WST a good stock to buy? We came across a bullish thesis on West Pharmaceutical Services, Inc. on MaxDividends’s Substack. In this article, we will summarize the bulls’ thesis on WST.
Dividend Kings and Aristocrats List: 32 Biggest Stocks
The markets have been churning all year. This picked up after the start of the Iran war on February 28 and the rally in crude oil prices.
Here is Why West Pharmaceutical Services, Inc. (WST) is Strongly Favored by Hedge Funds
On February 17, the governing body of West Pharmaceutical Services, Inc. (NYSE:WST) approved a new share repurchase program authorizing the buyback of up to $1 billion of its common stock.
10 Best Life Sciences Stocks to Buy According to Hedge Funds
Following a difficult start in 2025, the ever-evolving life sciences segment recovered strongly in the latter half of the year.
BofA Cuts West Pharmaceutical (WST) Target Following Model Update and Sector Pressure
On February 13, BofA lowered its price recommendation on West Pharmaceutical Services, Inc. (NYSE:WST) to $300 from $370. It reiterated a Buy rating on the stock.
13 Best Strong Buy Dividend Stocks to Invest In
In uncertain times, large companies that pay strong dividends tend to attract more attention, as these businesses generate profits supported by steady cash flows, which help sustain dividend payments ...
West Pharmaceutical Services (WST) is Returning to Sustainable Volume Growth
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2025 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2025 Earnings Call Transcript February 12, 2026West Pharmaceutical Services, Inc. misses on earnings expectations.
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory
We came across a bullish thesis on West Pharmaceutical Services, Inc. on TipRanks™’s YouTube Channel. In this article, we will summarize the bulls’ thesis on WST.